14 02, 2019 Lorenza Rimassa et al., Phase 2 study of tivantinib and cetuximab in KRAS wild-type metastatic colorectal cancer patients with acquired resistance to EGFR inhibitors and emergence of MET overexpression: lesson learned for future trials with EGFR/MET dual inhibition Diatech Pharmacogenetics2019-02-14T09:32:18+01:00 Mehr erfahren
15 11, 2018 Matteo Fassan et. al, miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis Diatech Pharmacogenetics2018-11-15T14:42:45+01:00 Mehr erfahren
10 08, 2017 Gianni Bussolati et al., Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples. Plos One Diatech Pharmacogenetics2017-08-10T10:35:58+02:00 Mehr erfahren
14 06, 2016 Riccardo Giannini et al., EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center. Oncology Reports Diatech Pharmacogenetics2016-06-14T11:50:34+02:00 Mehr erfahren
